Shoulder spacer from G21 receives FDA clearance
Click Here to Manage Email Alerts
G21 S.r.l. announced in a company press release that its SpaceFlex Shoulder, a custom modular spacer, has received FDA clearance.
“The achievement of this result for G21 means being able to offer a dedicated treatment of each infected joint,” Filippo Foroni, executive vice president of G21, said in the release.
According to the release, G21 is committed to providing patients with better health conditions and offers a range of products for orthopedics and minimally invasive spine surgery.
“The addition of SpaceFlex Shoulder to our product portfolio represents a user-friendly solution for complex issues,” Foroni said.